Diabetes types that require regular insulin treatment are highly dependent on the patient's ability to constantly track their blood glucose levels and self-administer insulin accordingly. This not only causes a major inconvenience in everyday life, but also involves the risk of hyperglycaemia or hypoglycaemia. In addition, a blood sugar deficiency can only be predicted inadequately in certain situations. Together with five European partners, researchers at the Fraunhofer EMFT are developing an implantable measuring and dosing system. It is capable of monitoring all relevant key metabolic parameters on a situation-specific basis and adjusting the insulin dosage accordingly.
more info